<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>US biopharma major Amgen to invest USD 200 million in its facility in Hyderabad</title>
    <link>https://www.taxtmi.com/news?id=35040</link>
    <description>Amgen announced an initial capital commitment to expand its Hyderabad manufacturing and R&amp;D operations in 2025, with additional significant investments planned in future years; the state framed the investment within an economic development and supply chain diversification strategy and invited research collaborations, skill development initiatives and academic partnerships to support long term growth.</description>
    <language>en-us</language>
    <pubDate>Mon, 24 Feb 2025 13:46:02 +0530</pubDate>
    <lastBuildDate>Mon, 24 Feb 2025 13:46:03 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=801028" rel="self" type="application/rss+xml"/>
    <item>
      <title>US biopharma major Amgen to invest USD 200 million in its facility in Hyderabad</title>
      <link>https://www.taxtmi.com/news?id=35040</link>
      <description>Amgen announced an initial capital commitment to expand its Hyderabad manufacturing and R&amp;D operations in 2025, with additional significant investments planned in future years; the state framed the investment within an economic development and supply chain diversification strategy and invited research collaborations, skill development initiatives and academic partnerships to support long term growth.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Mon, 24 Feb 2025 13:46:02 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=35040</guid>
    </item>
  </channel>
</rss>